Hypertrophic Cardiomyopathy-Need for Gene-Specific Treatment?-Reply
JAMA Cardiol
.
2019 Aug 1;4(8):831-832.
doi: 10.1001/jamacardio.2019.1766.
Authors
Caroline J Coats
1
2
,
Michael P Frenneaux
3
,
Perry M Elliott
1
4
Affiliations
1
UCL Institute of Cardiovascular Science, UCL Faculty of Population Health Sciences, University College London, London, United Kingdom.
2
Queen Elizabeth University Hospital, Glasgow, United Kingdom.
3
University of East Anglia, Norwich Research Park, Norwich, United Kingdom.
4
Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.
PMID:
31188395
DOI:
10.1001/jamacardio.2019.1766
No abstract available
Publication types
Comment
MeSH terms
Cardiomyopathy, Hypertrophic*
Exercise Tolerance
Humans
Mutation
Trimetazidine*
Substances
Trimetazidine